Similar articles

• [Clinical characteristics and therapeutic variations in elderly patients with ovarian cancer].

  Kihana T. Kihana T. Nihon Rinsho. 2004 Oct;62 Suppl 10:632-5. Nihon Rinsho. 2004. PMID: 15535322 Review. Japanese. No abstract available.
• [Therapy for ovarian cancer--general review].

  Ochiai K. Ochiai K. Nihon Rinsho. 2004 Oct;62 Suppl 10:517-21. Nihon Rinsho. 2004. PMID: 15535299 Review. Japanese. No abstract available.
• [Ovarian cancer treatment from the standpoint of the gynecologic oncologist].

  Sugiyama T, Yoshizaki A, Hatayama S. Sugiyama T, et al. Gan To Kagaku Ryoho. 2007 Jul;34(7):1011-6. Gan To Kagaku Ryoho. 2007. PMID: 17637537 Japanese.
• [Prognostic factors of ovarian cancer].

  Ochiai K. Ochiai K. Gan To Kagaku Ryoho. 2006 Dec;33(13):2014-9. Gan To Kagaku Ryoho. 2006. PMID: 17197745 Review. Japanese.
• For women receiving chemotherapy for clinically apparent early ovarian cancer, is there a benefit to surgical staging?

  Dizon DS, Restivo A, Lomme M, Charbonneau N, Brard L, Hughes T, Weitzen S, Legare R, Granai CO, Disilvestro P. Dizon DS, et al. Am J Clin Oncol. 2008 Feb;31(1):39-42. doi: 10.1097/COC.0b013e318134ee6f. Am J Clin Oncol. 2008. PMID: 18376226